VAERS reports by lot

GSK Varicella/Shingles lot CH2X7: VAERS reports

165 VAERS reports list lot CH2X7 as a GSK Varicella/Shingles vaccine, received between 2018-03-05 and 2019-03-25. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
165
Reports
10%
Marked serious
1
With a death outcome
13
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction17927%
General / Systemic (non-local)15022%
Musculoskeletal8012%
Neurological6710%
Dermatological (non-injection-site)6510%
Allergic / Anaphylactic507%
Cardiac / Cardiovascular274%
Gastrointestinal223%
Psychiatric / Neuropsychiatric142%
Respiratory112%
Reproductive / Menstrual20%
Thrombotic / Hematological10%
Autoimmune / Immune-mediated10%

Where reports came from

U.S. state of the reporter, where given (top 12).

California27
Washington18
New York13
Illinois12
Virginia10
Arizona8
Maryland6
New Mexico6
Ohio5
Montana5
Minnesota4
Indiana4

Reports by month received

2018-0310
2018-0443
2018-0552
2018-0621
2018-079
2018-089
2018-098
2018-105
2018-112
2018-121
2019-013
2019-021
2019-031

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.